InsiderTrades

Form 4 for PVLA PALVELLA THERAPEUTICS, INC.

Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001104659-26-006237 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-01-23 2026-01-21 PVLA Goin Kathleen COO S - Sale+OE $97.63 -4,302 3,749 -53% -$420.0K
DM 2026-01-23 2026-01-21 PVLA Goin Kathleen COO M - OptEx $8.11 +4,302 2,154 New +$34.9K
DM 2026-01-23 2026-01-21 PVLA Goin Kathleen COO M - OptEx $0.00 -4,302 19.3K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-21 S D 3,749 $97.94 0 D — —
2 Common Common Stock 2026-01-21 M A 2,148 $9.08 4,302 D — —
3 Common Common Stock 2026-01-21 M A 2,154 $7.14 2,154 D — —
4 Common Common Stock 2026-01-21 S D 553 $95.49 3,749 D — —
5 Derivative Stock Option (Right to Buy) 2026-01-21 M D 2,154 $0.00 19,397 D $7.14 · — to 2029-10-29 2,154 Common Stock (F2) The stock option is fully vested.
6 Derivative Stock Option (Right to Buy) 2026-01-21 M D 2,148 $0.00 19,332 D $9.08 · — to 2030-10-14 2,148 Common Stock (F2) The stock option is fully vested.